Update

What the Heck is EBITDA?

Our guest speakers will be discussing the most important financial metric in your practice.  EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization)  You will learn about the components of earnings that will affect the value of your practice on the Corporate Market. Dr. Gary Ackerman will conduct a panel discussion with industry leaders to review […]

Dr. Gary Ackerman

Our guest speakers will be discussing the most important financial metric in your practice.  EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization)  You will learn about the components of earnings that will affect the value of your practice on the Corporate Market. Dr. Gary Ackerman will conduct a panel discussion with industry leaders to review this very important metric.

Guest Speakers 

  • Karen E. Felsted DVM, PantheraT Veterinary Management Consulting
  • Geoff Pizinger, Senior Manager Business Development,  National Veterinary Associates
  • Steve Haas, Senior Financial Analyst, Ackerman Group

Corporate Consolidation of Veterinary Medicine

Our guest speakers will be discussing the current status of the Corporate Consolidation as well a looking at the next several years.  Large corporations have been investing in veterinary medicine for over 20 years.  These “consolidators” see the value that veterinary practices bring in terms of steady income and profit.  How many more practices do […]

Dr. Gary Ackerman

Our guest speakers will be discussing the current status of the Corporate Consolidation as well a looking at the next several years.  Large corporations have been investing in veterinary medicine for over 20 years.  These “consolidators” see the value that veterinary practices bring in terms of steady income and profit.  How many more practices do to they intend to buy and what does this mean for the state of the industry.    What does this mean for your transition plans and the market value of your practice?  Dr. Gary Ackerman will conduct a panel discussion with industry leaders to uncover the answers.

Guest Speakers 

  • Dr. Jay Price CEO, Southern Veterinary Partners
  • Mike Cooper Partner,  Shore Capital Partners
  • Trey Cutler Veterinary Attorney, Cutler Law Firm

Private Equity in Veterinary Medicine

Dr. Ackerman will be discussing the role of Private Equity Investors in practice sales.  Private Equity Investors are the driving force behind corporate acquisitions and demand continues to grow given the solid performance of veterinary medicine during the pandemic.  How does Private Equity return parameters affect the price and terms of your practice sale?   What does […]

Dr. Gary Ackerman

Dr. Ackerman will be discussing the role of Private Equity Investors in practice sales.  Private Equity Investors are the driving force behind corporate acquisitions and demand continues to grow given the solid performance of veterinary medicine during the pandemic.  How does Private Equity return parameters affect the price and terms of your practice sale?   What does all of this mean for your transition plans and the market value of your practice? Are corporate buyers still interested in your practice and at what price?  What affect have the financial markets had on lending and investment in veterinary practices. Dr. Gary Ackerman will conduct a panel discussion with industry leaders to uncover the answers.

Guest Speakers 

  • Kevin Ruffe CEO, Community Veterinary Partners
  • Peter Tanella , Veterinary Attorney, Mandelbaum Salsburg

Practice Sales for Dummies

Dr. Gary Ackerman will review the basics of selling your veterinary practice. If you have ever been intimidated by the language and terms used in practice sales this the Webinar for you. Dr. Ackerman will simplify terms like EBITDA, Joint Venture, Private Equity Roll-up, Tax Mitigation and Exit Multiples. We will have an extended question […]

Dr. Gary Ackerman

Dr. Gary Ackerman will review the basics of selling your veterinary practice. If you have ever been intimidated by the language and terms used in practice sales this the Webinar for you. Dr. Ackerman will simplify terms like EBITDA, Joint Venture, Private Equity Roll-up, Tax Mitigation and Exit Multiples. We will have an extended question and answer session that will clear up some of the confusion you may have regarding practice sales.

COVID 19 Market Update June 2020 & Step by Step Guide to Selling Your Practice

Dr. Ackerman gives an update on the “State of the Markets” with regard to the COVID-19 Pandemic. Dr. Ackerman will also guide you through the steps needed to sell your practice in today’s market.

Dr. Gary Ackerman

Dr. Ackerman gives an update on the “State of the Markets” with regard to the COVID-19 Pandemic. Dr. Ackerman will also guide you through the steps needed to sell your practice in today’s market.

COVID 19 Market Update May 2020

Dr. Ackerman discusses the corporate consolidation market with industry professionals. Michael Bland, Chief Development Officer, Pathway Chris Strong, Chief Executive Officer, People Pets and Vets Jeffrey Lipsitz, Co-President, Cortec Group Peter Tanella, Veterinary Attorney, Mandelaum Salsburg

Dr. Gary Ackerman

Dr. Ackerman discusses the corporate consolidation market with industry professionals.

  • Michael Bland, Chief Development Officer, Pathway
  • Chris Strong, Chief Executive Officer, People Pets and Vets
  • Jeffrey Lipsitz, Co-President, Cortec Group
  • Peter Tanella, Veterinary Attorney, Mandelaum Salsburg

COVID 19 Market Update April 2020

Dr. Ackerman discusses the corporate consolidation market with industry professionals. Glen Hanner, Tax Partner, WhitleyPenn – Not Recorded Brian Kelly, President, NVA – Speaking at begining of recording  Steve Ager, Chief Development Officer, NVA Edward Guiducci, Founding Partner, Guiducci & Guiducci PC Eric Smith, General Counsel, NVA

Dr. Gary Ackerman

Dr. Ackerman discusses the corporate consolidation market with industry professionals.

  • Glen Hanner, Tax Partner, WhitleyPenn – Not Recorded
  • Brian Kelly, President, NVA – Speaking at begining of recording 
  • Steve Ager, Chief Development Officer, NVA
  • Edward Guiducci, Founding Partner, Guiducci & Guiducci PC
  • Eric Smith, General Counsel, NVA

COVID 19 Market Update March 2020

Veterinary owners are doing all they can to cope with the current pandemic.  What does this mean for your transition plans?  How has the current shut down of the economy affected corporate buyers?  Dr. Ackerman discusses the market with industry leaders. Michael Aubrey, CEO Mission Veterinary Partners Dan Eisenstadt, CEO Terravet Real Estate Solutions Trey Cutler  […]

Dr. Gary Ackerman

Veterinary owners are doing all they can to cope with the current pandemic.  What does this mean for your transition plans?  How has the current shut down of the economy affected corporate buyers?  Dr. Ackerman discusses the market with industry leaders.

  • Michael Aubrey, CEO Mission Veterinary Partners
  • Dan Eisenstadt, CEO Terravet Real Estate Solutions
  • Trey Cutler   Cutler Law Firm – Veterinary Legal Services

When Should I Sell my Practice

Dr. Ackerman discusses the factors your should consider before selling your practice.  Is this the right time to sell or should I wait?

Dr. Gary Ackerman

Dr. Ackerman discusses the factors your should consider before selling your practice.  Is this the right time to sell or should I wait?

Veterinary Practice Consolidation Demystified

Link to an excellent article about private equity in the corporate market. Authors Michael Dicks and Melissa Maddux explain the role of private equity and the effect on valuations.

Michael Dicks, Melissa Maddux

Link to an excellent article about private equity in the corporate market. Authors Michael Dicks and Melissa Maddux explain the role of private equity and the effect on valuations.